Michael Eamon Peter O'dwyer,Jinsong Hu,Michael Eamon Peter Odwyer
申请号：
US15837603
公开号：
US20180344768A1
申请日:
2017.12.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed herein are methods of cancer treatment comprising administration of a natural killer (NK) cell or cell line in combination with an IL-6 antagonist, such as an antibody to IL-6 or its receptor, especially for treatment of cancer expressing IL-6 receptors and in which checkpoint inhibitory receptors, such as PDL-1 and/or PDL-2 are expressed/upregulated during disease.
